Eastgate Biotech Corp.
OTC: ETBI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Rosella C. Perri
- Employees
- 2
- Headquarters
- Toronto, United States
- IPO year
- 2014
- Market cap
- $6.2M
- Website
- www.EastGateBiotech.com
Loading ETBI…
Loading profile data…Frequently asked questions about ETBI
What does Eastgate Biotech Corp. (ETBI) do?
EastGate Biotech Corp. is a pharmaceutical company specializing in the production and distribution of nutraceuticals. These products are rooted in natural therapies and designed for natural absorption within the body. The firm employs cutting-edge nanotechnologies to provide healthier options compared to conventional pharmaceuticals, which often...
Where does ETBI trade?
Eastgate Biotech Corp. (ETBI) trades on the Other OTC.
What sector is ETBI in?
Eastgate Biotech Corp. (ETBI) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Eastgate Biotech Corp.?
Rosella C. Perri is the chief executive officer of Eastgate Biotech Corp. (ETBI).
Where is Eastgate Biotech Corp. headquartered?
Eastgate Biotech Corp. is headquartered in United States.
Does ETBI pay a dividend?
Eastgate Biotech Corp. (ETBI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ETBI go public?
Eastgate Biotech Corp. (ETBI) completed its initial public offering in 2014.